In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Interferon Alpha-2a Biosimilar market for 2018-2023.
Interferon a (human leukocyte protein moiety reduced). A type I interferon consisting of 165 amino acid residues with lysine in position 23. This protein is produced by recombinant DNA technology and resembles interferon secreted by leukocytes. It is used extensively as an antiviral or antineoplastic agent. An oral form is being developed by Amarillo Biosciences.
The global average price of Interferon Alpha-2a Biosimilar is in the decreasing trend, from 186.78 USD/Unit in 2013 to 64.67 USD/Unit in 2017. With the situation of global economy, prices will be in decreasing trend in the following five years.
The classification of Interferon Alpha-2a Biosimilar includes ordinary type and long-lasting type, and the proportion of ordinary type in 2017 is about 64%, and the proportion is in increasing trend from 2013 to 2017.
Interferon Alpha-2a Biosimilar is widely used for hepatitis C, hepatitis B and other diseases. The most proportion of Interferon Alpha-2a Biosimilar is used for hepatitis C, and the proportion in 2017 is 46%.
Europe is the largest supplier of Interferon Alpha-2a Biosimilar, with a production market share nearly 70% in 2017.
South America is the largest consumption place, with a consumption market share nearly 26% in 2017. Following South America, Europe is the second largest consumption place with the consumption market share of 22%.
Market competition is not intense. Roche, Biosidus, Zydus Cadila, Nanogen, Amega Biotech, Rhein Minapharm Biogenetics, PROBIOMED, 3sbio, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
Over the next five years, LPI(LP Information) projects that Interferon Alpha-2a Biosimilar will register a -11.2% CAGR in terms of revenue, reach US$ 190 million by 2023, from US$ 390 million in 2017.
This report presents a comprehensive overview, market shares, and growth opportunities of Interferon Alpha-2a Biosimilar market by product type, application, key manufacturers and key regions.
To calculate the market size, LP Information considers value and volume generated from the sales of the following segments:
Segmentation by product type:
Long-lasting Type
Ordinary Type
Segmentation by application:
Hepatitis C
Hepatitis B
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:
Roche
Biosidus
Zydus Cadila
Nanogen
Amega Biotech
Rhein Minapharm Biogenetics
PROBIOMED
3sbio
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Interferon Alpha-2a Biosimilar consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
To understand the structure of Interferon Alpha-2a Biosimilar market by identifying its various subsegments.
Focuses on the key global Interferon Alpha-2a Biosimilar manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Interferon Alpha-2a Biosimilar with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Interferon Alpha-2a Biosimilar submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2018-2023 Global Interferon Alpha-2a Biosimilar Consumption Market Report
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Interferon Alpha-2a Biosimilar Consumption 2013-2023
2.1.2 Interferon Alpha-2a Biosimilar Consumption CAGR by Region
2.2 Interferon Alpha-2a Biosimilar Segment by Type
2.2.1 Long-lasting Type
2.2.2 Ordinary Type
2.3 Interferon Alpha-2a Biosimilar Consumption by Type
2.3.1 Global Interferon Alpha-2a Biosimilar Consumption Market Share by Type (2013-2018)
2.3.2 Global Interferon Alpha-2a Biosimilar Revenue and Market Share by Type (2013-2018)
2.3.3 Global Interferon Alpha-2a Biosimilar Sale Price by Type (2013-2018)
2.4 Interferon Alpha-2a Biosimilar Segment by Application
2.4.1 Hepatitis C
2.4.2 Hepatitis B
2.4.3 Other
2.5 Interferon Alpha-2a Biosimilar Consumption by Application
2.5.1 Global Interferon Alpha-2a Biosimilar Consumption Market Share by Application (2013-2018)
2.5.2 Global Interferon Alpha-2a Biosimilar Value and Market Share by Application (2013-2018)
2.5.3 Global Interferon Alpha-2a Biosimilar Sale Price by Application (2013-2018)
3 Global Interferon Alpha-2a Biosimilar by Players
3.1 Global Interferon Alpha-2a Biosimilar Sales Market Share by Players
3.1.1 Global Interferon Alpha-2a Biosimilar Sales by Players (2016-2018)
3.1.2 Global Interferon Alpha-2a Biosimilar Sales Market Share by Players (2016-2018)
3.2 Global Interferon Alpha-2a Biosimilar Revenue Market Share by Players
3.2.1 Global Interferon Alpha-2a Biosimilar Revenue by Players (2016-2018)
3.2.2 Global Interferon Alpha-2a Biosimilar Revenue Market Share by Players (2016-2018)
3.3 Global Interferon Alpha-2a Biosimilar Sale Price by Players
3.4 Global Interferon Alpha-2a Biosimilar Manufacturing Base Distribution, Sales Area, Product Types by Players
3.4.1 Global Interferon Alpha-2a Biosimilar Manufacturing Base Distribution and Sales Area by Players
3.4.2 Players Interferon Alpha-2a Biosimilar Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Interferon Alpha-2a Biosimilar by Regions
4.1 Interferon Alpha-2a Biosimilar by Regions
4.1.1 Global Interferon Alpha-2a Biosimilar Consumption by Regions
4.1.2 Global Interferon Alpha-2a Biosimilar Value by Regions
4.2 Americas Interferon Alpha-2a Biosimilar Consumption Growth
4.3 APAC Interferon Alpha-2a Biosimilar Consumption Growth
4.4 Europe Interferon Alpha-2a Biosimilar Consumption Growth
4.5 Middle East & Africa Interferon Alpha-2a Biosimilar Consumption Growth
5 Americas
5.1 Americas Interferon Alpha-2a Biosimilar Consumption by Countries
5.1.1 Americas Interferon Alpha-2a Biosimilar Consumption by Countries (2013-2018)
5.1.2 Americas Interferon Alpha-2a Biosimilar Value by Countries (2013-2018)
5.2 Americas Interferon Alpha-2a Biosimilar Consumption by Type
5.3 Americas Interferon Alpha-2a Biosimilar Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Interferon Alpha-2a Biosimilar Consumption by Countries
6.1.1 APAC Interferon Alpha-2a Biosimilar Consumption by Countries (2013-2018)
6.1.2 APAC Interferon Alpha-2a Biosimilar Value by Countries (2013-2018)
6.2 APAC Interferon Alpha-2a Biosimilar Consumption by Type
6.3 APAC Interferon Alpha-2a Biosimilar Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries
7 Europe
7.1 Europe Interferon Alpha-2a Biosimilar by Countries
7.1.1 Europe Interferon Alpha-2a Biosimilar Consumption by Countries (2013-2018)
7.1.2 Europe Interferon Alpha-2a Biosimilar Value by Countries (2013-2018)
7.2 Europe Interferon Alpha-2a Biosimilar Consumption by Type
7.3 Europe Interferon Alpha-2a Biosimilar Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Interferon Alpha-2a Biosimilar by Countries
8.1.1 Middle East & Africa Interferon Alpha-2a Biosimilar Consumption by Countries (2013-2018)
8.1.2 Middle East & Africa Interferon Alpha-2a Biosimilar Value by Countries (2013-2018)
8.2 Middle East & Africa Interferon Alpha-2a Biosimilar Consumption by Type
8.3 Middle East & Africa Interferon Alpha-2a Biosimilar Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.2 Interferon Alpha-2a Biosimilar Distributors
10.3 Interferon Alpha-2a Biosimilar Customer
11 Global Interferon Alpha-2a Biosimilar Market Forecast
11.1 Global Interferon Alpha-2a Biosimilar Consumption Forecast (2018-2023)
11.2 Global Interferon Alpha-2a Biosimilar Forecast by Regions
11.2.1 Global Interferon Alpha-2a Biosimilar Forecast by Regions (2018-2023)
11.2.2 Global Interferon Alpha-2a Biosimilar Value Forecast by Regions (2018-2023)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Interferon Alpha-2a Biosimilar Forecast by Type
11.8 Global Interferon Alpha-2a Biosimilar Forecast by Application
12 Key Players Analysis
12.1 Roche
12.1.1 Company Details
12.1.2 Interferon Alpha-2a Biosimilar Product Offered
12.1.3 Roche Interferon Alpha-2a Biosimilar Sales, Revenue, Price and Gross Margin (2016-2018)
12.1.4 Main Business Overview
12.1.5 Roche News
12.2 Biosidus
12.2.1 Company Details
12.2.2 Interferon Alpha-2a Biosimilar Product Offered
12.2.3 Biosidus Interferon Alpha-2a Biosimilar Sales, Revenue, Price and Gross Margin (2016-2018)
12.2.4 Main Business Overview
12.2.5 Biosidus News
12.3 Zydus Cadila
12.3.1 Company Details
12.3.2 Interferon Alpha-2a Biosimilar Product Offered
12.3.3 Zydus Cadila Interferon Alpha-2a Biosimilar Sales, Revenue, Price and Gross Margin (2016-2018)
12.3.4 Main Business Overview
12.3.5 Zydus Cadila News
12.4 Nanogen
12.4.1 Company Details
12.4.2 Interferon Alpha-2a Biosimilar Product Offered
12.4.3 Nanogen Interferon Alpha-2a Biosimilar Sales, Revenue, Price and Gross Margin (2016-2018)
12.4.4 Main Business Overview
12.4.5 Nanogen News
12.5 Amega Biotech
12.5.1 Company Details
12.5.2 Interferon Alpha-2a Biosimilar Product Offered
12.5.3 Amega Biotech Interferon Alpha-2a Biosimilar Sales, Revenue, Price and Gross Margin (2016-2018)
12.5.4 Main Business Overview
12.5.5 Amega Biotech News
12.6 Rhein Minapharm Biogenetics
12.6.1 Company Details
12.6.2 Interferon Alpha-2a Biosimilar Product Offered
12.6.3 Rhein Minapharm Biogenetics Interferon Alpha-2a Biosimilar Sales, Revenue, Price and Gross Margin (2016-2018)
12.6.4 Main Business Overview
12.6.5 Rhein Minapharm Biogenetics News
12.7 PROBIOMED
12.7.1 Company Details
12.7.2 Interferon Alpha-2a Biosimilar Product Offered
12.7.3 PROBIOMED Interferon Alpha-2a Biosimilar Sales, Revenue, Price and Gross Margin (2016-2018)
12.7.4 Main Business Overview
12.7.5 PROBIOMED News
12.8 3sbio
12.8.1 Company Details
12.8.2 Interferon Alpha-2a Biosimilar Product Offered
12.8.3 3sbio Interferon Alpha-2a Biosimilar Sales, Revenue, Price and Gross Margin (2016-2018)
12.8.4 Main Business Overview
12.8.5 3sbio News
13 Research Findings and Conclusion
List of Tables and Figures
Figure Picture of Interferon Alpha-2a Biosimilar
Table Product Specifications of Interferon Alpha-2a Biosimilar
Figure Interferon Alpha-2a Biosimilar Report Years Considered
Figure Market Research Methodology
Figure Global Interferon Alpha-2a Biosimilar Consumption Growth Rate 2013-2023 (K Units)
Figure Global Interferon Alpha-2a Biosimilar Value Growth Rate 2013-2023 ($ Millions)
Table Interferon Alpha-2a Biosimilar Consumption CAGR by Region 2013-2023 ($ Millions)
Figure Product Picture of Long-lasting Type
Table Major Players of Long-lasting Type
Figure Product Picture of Ordinary Type
Table Major Players of Ordinary Type
Table Global Consumption Sales by Type (2013-2018)
Table Global Interferon Alpha-2a Biosimilar Consumption Market Share by Type (2013-2018)
Figure Global Interferon Alpha-2a Biosimilar Consumption Market Share by Type (2013-2018)
Table Global Interferon Alpha-2a Biosimilar Revenue by Type (2013-2018) ($ million)
Table Global Interferon Alpha-2a Biosimilar Value Market Share by Type (2013-2018) ($ Millions)
Figure Global Interferon Alpha-2a Biosimilar Value Market Share by Type (2013-2018)
Table Global Interferon Alpha-2a Biosimilar Sale Price by Type (2013-2018)
Figure Interferon Alpha-2a Biosimilar Consumed in Hepatitis C
Figure Global Interferon Alpha-2a Biosimilar Market: Hepatitis C (2013-2018) (K Units)
Figure Global Interferon Alpha-2a Biosimilar Market: Hepatitis C (2013-2018) ($ Millions)
Figure Global Hepatitis C YoY Growth ($ Millions)
Figure Interferon Alpha-2a Biosimilar Consumed in Hepatitis B
Figure Global Interferon Alpha-2a Biosimilar Market: Hepatitis B (2013-2018) (K Units)
Figure Global Interferon Alpha-2a Biosimilar Market: Hepatitis B (2013-2018) ($ Millions)
Figure Global Hepatitis B YoY Growth ($ Millions)
Figure Interferon Alpha-2a Biosimilar Consumed in Other
Figure Global Interferon Alpha-2a Biosimilar Market: Other (2013-2018) (K Units)
Figure Global Interferon Alpha-2a Biosimilar Market: Other (2013-2018) ($ Millions)
Figure Global Other YoY Growth ($ Millions)
Table Global Consumption Sales by Application (2013-2018)
Table Global Interferon Alpha-2a Biosimilar Consumption Market Share by Application (2013-2018)
Figure Global Interferon Alpha-2a Biosimilar Consumption Market Share by Application (2013-2018)
Table Global Interferon Alpha-2a Biosimilar Value by Application (2013-2018)
Table Global Interferon Alpha-2a Biosimilar Value Market Share by Application (2013-2018)
Figure Global Interferon Alpha-2a Biosimilar Value Market Share by Application (2013-2018)
Table Global Interferon Alpha-2a Biosimilar Sale Price by Application (2013-2018)
Table Global Interferon Alpha-2a Biosimilar Sales by Players (2016-2018) (K Units)
Table Global Interferon Alpha-2a Biosimilar Sales Market Share by Players (2016-2018)
Figure Global Interferon Alpha-2a Biosimilar Sales Market Share by Players in 2016
Figure Global Interferon Alpha-2a Biosimilar Sales Market Share by Players in 2017
Table Global Interferon Alpha-2a Biosimilar Revenue by Players (2016-2018) ($ Millions)
Table Global Interferon Alpha-2a Biosimilar Revenue Market Share by Players (2016-2018)
Figure Global Interferon Alpha-2a Biosimilar Revenue Market Share by Players in 2016
Figure Global Interferon Alpha-2a Biosimilar Revenue Market Share by Players in 2017
Table Global Interferon Alpha-2a Biosimilar Sale Price by Players (2016-2018)
Figure Global Interferon Alpha-2a Biosimilar Sale Price by Players in 2017
Table Global Interferon Alpha-2a Biosimilar Manufacturing Base Distribution and Sales Area by Players
Table Players Interferon Alpha-2a Biosimilar Products Offered
Table Interferon Alpha-2a Biosimilar Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
Table Global Interferon Alpha-2a Biosimilar Consumption by Regions 2013-2018 (K Units)
Table Global Interferon Alpha-2a Biosimilar Consumption Market Share by Regions 2013-2018
Figure Global Interferon Alpha-2a Biosimilar Consumption Market Share by Regions 2013-2018
Table Global Interferon Alpha-2a Biosimilar Value by Regions 2013-2018 ($ Millions)
Table Global Interferon Alpha-2a Biosimilar Value Market Share by Regions 2013-2018
Figure Global Interferon Alpha-2a Biosimilar Value Market Share by Regions 2013-2018
Figure Americas Interferon Alpha-2a Biosimilar Consumption 2013-2018 (K Units)
Figure Americas Interferon Alpha-2a Biosimilar Value 2013-2018 ($ Millions)
Figure APAC Interferon Alpha-2a Biosimilar Consumption 2013-2018 (K Units)
Figure APAC Interferon Alpha-2a Biosimilar Value 2013-2018 ($ Millions)
Figure Europe Interferon Alpha-2a Biosimilar Consumption 2013-2018 (K Units)
Figure Europe Interferon Alpha-2a Biosimilar Value 2013-2018 ($ Millions)
Figure Middle East & Africa Interferon Alpha-2a Biosimilar Consumption 2013-2018 (K Units)
Figure Middle East & Africa Interferon Alpha-2a Biosimilar Value 2013-2018 ($ Millions)
Table Americas Interferon Alpha-2a Biosimilar Consumption by Countries (2013-2018) (K Units)
Table Americas Interferon Alpha-2a Biosimilar Consumption Market Share by Countries (2013-2018)
Figure Americas Interferon Alpha-2a Biosimilar Consumption Market Share by Countries in 2017
Table Americas Interferon Alpha-2a Biosimilar Value by Countries (2013-2018) ($ Millions)
Table Americas Interferon Alpha-2a Biosimilar Value Market Share by Countries (2013-2018)
Figure Americas Interferon Alpha-2a Biosimilar Value Market Share by Countries in 2017
Table Americas Interferon Alpha-2a Biosimilar Consumption by Type (2013-2018) (K Units)
Table Americas Interferon Alpha-2a Biosimilar Consumption Market Share by Type (2013-2018)
Figure Americas Interferon Alpha-2a Biosimilar Consumption Market Share by Type in 2017
Table Americas Interferon Alpha-2a Biosimilar Consumption by Application (2013-2018) (K Units)
Table Americas Interferon Alpha-2a Biosimilar Consumption Market Share by Application (2013-2018)
Figure Americas Interferon Alpha-2a Biosimilar Consumption Market Share by Application in 2017
Figure United States Interferon Alpha-2a Biosimilar Consumption Growth 2013-2018 (K Units)
Figure United States Interferon Alpha-2a Biosimilar Value Growth 2013-2018 ($ Millions)
Figure Canada Interferon Alpha-2a Biosimilar Consumption Growth 2013-2018 (K Units)
Figure Canada Interferon Alpha-2a Biosimilar Value Growth 2013-2018 ($ Millions)
Figure Mexico Interferon Alpha-2a Biosimilar Consumption Growth 2013-2018 (K Units)
Figure Mexico Interferon Alpha-2a Biosimilar Value Growth 2013-2018 ($ Millions)
Table APAC Interferon Alpha-2a Biosimilar Consumption by Countries (2013-2018) (K Units)
Table APAC Interferon Alpha-2a Biosimilar Consumption Market Share by Countries (2013-2018)
Figure APAC Interferon Alpha-2a Biosimilar Consumption Market Share by Countries in 2017
Table APAC Interferon Alpha-2a Biosimilar Value by Countries (2013-2018) ($ Millions)
Table APAC Interferon Alpha-2a Biosimilar Value Market Share by Countries (2013-2018)
Figure APAC Interferon Alpha-2a Biosimilar Value Market Share by Countries in 2017
Table APAC Interferon Alpha-2a Biosimilar Consumption by Type (2013-2018) (K Units)
Table APAC Interferon Alpha-2a Biosimilar Consumption Market Share by Type (2013-2018)
Figure APAC Interferon Alpha-2a Biosimilar Consumption Market Share by Type in 2017
Table APAC Interferon Alpha-2a Biosimilar Consumption by Application (2013-2018) (K Units)
Table APAC Interferon Alpha-2a Biosimilar Consumption Market Share by Application (2013-2018)
Figure APAC Interferon Alpha-2a Biosimilar Consumption Market Share by Application in 2017
Figure China Interferon Alpha-2a Biosimilar Consumption Growth 2013-2018 (K Units)
Figure China Interferon Alpha-2a Biosimilar Value Growth 2013-2018 ($ Millions)
Figure Japan Interferon Alpha-2a Biosimilar Consumption Growth 2013-2018 (K Units)
Figure Japan Interferon Alpha-2a Biosimilar Value Growth 2013-2018 ($ Millions)
Figure Korea Interferon Alpha-2a Biosimilar Consumption Growth 2013-2018 (K Units)
Figure Korea Interferon Alpha-2a Biosimilar Value Growth 2013-2018 ($ Millions)
Figure Southeast Asia Interferon Alpha-2a Biosimilar Consumption Growth 2013-2018 (K Units)
Figure Southeast Asia Interferon Alpha-2a Biosimilar Value Growth 2013-2018 ($ Millions)
Figure India Interferon Alpha-2a Biosimilar Consumption Growth 2013-2018 (K Units)
Figure India Interferon Alpha-2a Biosimilar Value Growth 2013-2018 ($ Millions)
Figure Australia Interferon Alpha-2a Biosimilar Consumption Growth 2013-2018 (K Units)
Figure Australia Interferon Alpha-2a Biosimilar Value Growth 2013-2018 ($ Millions)
Table Europe Interferon Alpha-2a Biosimilar Consumption by Countries (2013-2018) (K Units)
Table Europe Interferon Alpha-2a Biosimilar Consumption Market Share by Countries (2013-2018)
Figure Europe Interferon Alpha-2a Biosimilar Consumption Market Share by Countries in 2017
Table Europe Interferon Alpha-2a Biosimilar Value by Countries (2013-2018) ($ Millions)
Table Europe Interferon Alpha-2a Biosimilar Value Market Share by Countries (2013-2018)
Figure Europe Interferon Alpha-2a Biosimilar Value Market Share by Countries in 2017
Table Europe Interferon Alpha-2a Biosimilar Consumption by Type (2013-2018) (K Units)
Table Europe Interferon Alpha-2a Biosimilar Consumption Market Share by Type (2013-2018)
Figure Europe Interferon Alpha-2a Biosimilar Consumption Market Share by Type in 2017
Table Europe Interferon Alpha-2a Biosimilar Consumption by Application (2013-2018) (K Units)
Table Europe Interferon Alpha-2a Biosimilar Consumption Market Share by Application (2013-2018)
Figure Europe Interferon Alpha-2a Biosimilar Consumption Market Share by Application in 2017
Figure Germany Interferon Alpha-2a Biosimilar Consumption Growth 2013-2018 (K Units)
Figure Germany Interferon Alpha-2a Biosimilar Value Growth 2013-2018 ($ Millions)
Figure France Interferon Alpha-2a Biosimilar Consumption Growth 2013-2018 (K Units)
Figure France Interferon Alpha-2a Biosimilar Value Growth 2013-2018 ($ Millions)
Figure UK Interferon Alpha-2a Biosimilar Consumption Growth 2013-2018 (K Units)
Figure UK Interferon Alpha-2a Biosimilar Value Growth 2013-2018 ($ Millions)
Figure Italy Interferon Alpha-2a Biosimilar Consumption Growth 2013-2018 (K Units)
Figure Italy Interferon Alpha-2a Biosimilar Value Growth 2013-2018 ($ Millions)
Figure Russia Interferon Alpha-2a Biosimilar Consumption Growth 2013-2018 (K Units)
Figure Russia Interferon Alpha-2a Biosimilar Value Growth 2013-2018 ($ Millions)
Figure Spain Interferon Alpha-2a Biosimilar Consumption Growth 2013-2018 (K Units)
Figure Spain Interferon Alpha-2a Biosimilar Value Growth 2013-2018 ($ Millions)
Table Middle East & Africa Interferon Alpha-2a Biosimilar Consumption by Countries (2013-2018) (K Units)
Table Middle East & Africa Interferon Alpha-2a Biosimilar Consumption Market Share by Countries (2013-2018)
Figure Middle East & Africa Interferon Alpha-2a Biosimilar Consumption Market Share by Countries in 2017
Table Middle East & Africa Interferon Alpha-2a Biosimilar Value by Countries (2013-2018) ($ Millions)
Table Middle East & Africa Interferon Alpha-2a Biosimilar Value Market Share by Countries (2013-2018)
Figure Middle East & Africa Interferon Alpha-2a Biosimilar Value Market Share by Countries in 2017
Table Middle East & Africa Interferon Alpha-2a Biosimilar Consumption by Type (2013-2018) (K Units)
Table Middle East & Africa Interferon Alpha-2a Biosimilar Consumption Market Share by Type (2013-2018)
Figure Middle East & Africa Interferon Alpha-2a Biosimilar Consumption Market Share by Type in 2017
Table Middle East & Africa Interferon Alpha-2a Biosimilar Consumption by Application (2013-2018) (K Units)
Table Middle East & Africa Interferon Alpha-2a Biosimilar Consumption Market Share by Application (2013-2018)
Figure Middle East & Africa Interferon Alpha-2a Biosimilar Consumption Market Share by Application in 2017
Figure Egypt Interferon Alpha-2a Biosimilar Consumption Growth 2013-2018 (K Units)
Figure Egypt Interferon Alpha-2a Biosimilar Value Growth 2013-2018 ($ Millions)
Figure South Africa Interferon Alpha-2a Biosimilar Consumption Growth 2013-2018 (K Units)
Figure South Africa Interferon Alpha-2a Biosimilar Value Growth 2013-2018 ($ Millions)
Figure Israel Interferon Alpha-2a Biosimilar Consumption Growth 2013-2018 (K Units)
Figure Israel Interferon Alpha-2a Biosimilar Value Growth 2013-2018 ($ Millions)
Figure Turkey Interferon Alpha-2a Biosimilar Consumption Growth 2013-2018 (K Units)
Figure Turkey Interferon Alpha-2a Biosimilar Value Growth 2013-2018 ($ Millions)
Figure GCC Countries Interferon Alpha-2a Biosimilar Consumption Growth 2013-2018 (K Units)
Figure GCC Countries Interferon Alpha-2a Biosimilar Value Growth 2013-2018 ($ Millions)
Table Interferon Alpha-2a Biosimilar Distributors List
Table Interferon Alpha-2a Biosimilar Customer List
Figure Global Interferon Alpha-2a Biosimilar Consumption Growth Rate Forecast (2018-2023) (K Units)
Figure Global Interferon Alpha-2a Biosimilar Value Growth Rate Forecast (2018-2023) ($ Millions)
Table Global Interferon Alpha-2a Biosimilar Consumption Forecast by Countries (2018-2023) (K Units)
Table Global Interferon Alpha-2a Biosimilar Consumption Market Forecast by Regions
Table Global Interferon Alpha-2a Biosimilar Value Forecast by Countries (2018-2023) ($ Millions)
Table Global Interferon Alpha-2a Biosimilar Value Market Share Forecast by Regions
Figure Americas Interferon Alpha-2a Biosimilar Consumption 2018-2023 (K Units)
Figure Americas Interferon Alpha-2a Biosimilar Value 2018-2023 ($ Millions)
Figure APAC Interferon Alpha-2a Biosimilar Consumption 2018-2023 (K Units)
Figure APAC Interferon Alpha-2a Biosimilar Value 2018-2023 ($ Millions)
Figure Europe Interferon Alpha-2a Biosimilar Consumption 2018-2023 (K Units)
Figure Europe Interferon Alpha-2a Biosimilar Value 2018-2023 ($ Millions)
Figure Middle East & Africa Interferon Alpha-2a Biosimilar Consumption 2018-2023 (K Units)
Figure Middle East & Africa Interferon Alpha-2a Biosimilar Value 2018-2023 ($ Millions)
Figure United States Interferon Alpha-2a Biosimilar Consumption 2018-2023 (K Units)
Figure United States Interferon Alpha-2a Biosimilar Value 2018-2023 ($ Millions)
Figure Canada Interferon Alpha-2a Biosimilar Consumption 2018-2023 (K Units)
Figure Canada Interferon Alpha-2a Biosimilar Value 2018-2023 ($ Millions)
Figure Mexico Interferon Alpha-2a Biosimilar Consumption 2018-2023 (K Units)
Figure Mexico Interferon Alpha-2a Biosimilar Value 2018-2023 ($ Millions)
Figure Brazil Interferon Alpha-2a Biosimilar Consumption 2018-2023 (K Units)
Figure Brazil Interferon Alpha-2a Biosimilar Value 2018-2023 ($ Millions)
Figure China Interferon Alpha-2a Biosimilar Consumption 2018-2023 (K Units)
Figure China Interferon Alpha-2a Biosimilar Value 2018-2023 ($ Millions)
Figure Japan Interferon Alpha-2a Biosimilar Consumption 2018-2023 (K Units)
Figure Japan Interferon Alpha-2a Biosimilar Value 2018-2023 ($ Millions)
Figure Korea Interferon Alpha-2a Biosimilar Consumption 2018-2023 (K Units)
Figure Korea Interferon Alpha-2a Biosimilar Value 2018-2023 ($ Millions)
Figure Southeast Asia Interferon Alpha-2a Biosimilar Consumption 2018-2023 (K Units)
Figure Southeast Asia Interferon Alpha-2a Biosimilar Value 2018-2023 ($ Millions)
Figure India Interferon Alpha-2a Biosimilar Consumption 2018-2023 (K Units)
Figure India Interferon Alpha-2a Biosimilar Value 2018-2023 ($ Millions)
Figure Australia Interferon Alpha-2a Biosimilar Consumption 2018-2023 (K Units)
Figure Australia Interferon Alpha-2a Biosimilar Value 2018-2023 ($ Millions)
Figure Germany Interferon Alpha-2a Biosimilar Consumption 2018-2023 (K Units)
Figure Germany Interferon Alpha-2a Biosimilar Value 2018-2023 ($ Millions)
Figure France Interferon Alpha-2a Biosimilar Consumption 2018-2023 (K Units)
Figure France Interferon Alpha-2a Biosimilar Value 2018-2023 ($ Millions)
Figure UK Interferon Alpha-2a Biosimilar Consumption 2018-2023 (K Units)
Figure UK Interferon Alpha-2a Biosimilar Value 2018-2023 ($ Millions)
Figure Italy Interferon Alpha-2a Biosimilar Consumption 2018-2023 (K Units)
Figure Italy Interferon Alpha-2a Biosimilar Value 2018-2023 ($ Millions)
Figure Russia Interferon Alpha-2a Biosimilar Consumption 2018-2023 (K Units)
Figure Russia Interferon Alpha-2a Biosimilar Value 2018-2023 ($ Millions)
Figure Spain Interferon Alpha-2a Biosimilar Consumption 2018-2023 (K Units)
Figure Spain Interferon Alpha-2a Biosimilar Value 2018-2023 ($ Millions)
Figure Egypt Interferon Alpha-2a Biosimilar Consumption 2018-2023 (K Units)
Figure Egypt Interferon Alpha-2a Biosimilar Value 2018-2023 ($ Millions)
Figure South Africa Interferon Alpha-2a Biosimilar Consumption 2018-2023 (K Units)
Figure South Africa Interferon Alpha-2a Biosimilar Value 2018-2023 ($ Millions)
Figure Israel Interferon Alpha-2a Biosimilar Consumption 2018-2023 (K Units)
Figure Israel Interferon Alpha-2a Biosimilar Value 2018-2023 ($ Millions)
Figure Turkey Interferon Alpha-2a Biosimilar Consumption 2018-2023 (K Units)
Figure Turkey Interferon Alpha-2a Biosimilar Value 2018-2023 ($ Millions)
Figure GCC Countries Interferon Alpha-2a Biosimilar Consumption 2018-2023 (K Units)
Figure GCC Countries Interferon Alpha-2a Biosimilar Value 2018-2023 ($ Millions)
Table Global Interferon Alpha-2a Biosimilar Consumption Forecast by Type (2018-2023) (K Units)
Table Global Interferon Alpha-2a Biosimilar Consumption Market Share Forecast by Type (2018-2023)
Table Global Interferon Alpha-2a Biosimilar Value Forecast by Type (2018-2023) ($ Millions)
Table Global Interferon Alpha-2a Biosimilar Value Market Share Forecast by Type (2018-2023)
Table Global Interferon Alpha-2a Biosimilar Consumption Forecast by Application (2018-2023) (K Units)
Table Global Interferon Alpha-2a Biosimilar Consumption Market Share Forecast by Application (2018-2023)
Table Global Interferon Alpha-2a Biosimilar Value Forecast by Application (2018-2023) ($ Millions)
Table Global Interferon Alpha-2a Biosimilar Value Market Share Forecast by Application (2018-2023)
Table Roche Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Roche Interferon Alpha-2a Biosimilar Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Roche Interferon Alpha-2a Biosimilar Market Share (2016-2018)
Table Biosidus Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Biosidus Interferon Alpha-2a Biosimilar Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Biosidus Interferon Alpha-2a Biosimilar Market Share (2016-2018)
Table Zydus Cadila Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Zydus Cadila Interferon Alpha-2a Biosimilar Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Zydus Cadila Interferon Alpha-2a Biosimilar Market Share (2016-2018)
Table Nanogen Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Nanogen Interferon Alpha-2a Biosimilar Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Nanogen Interferon Alpha-2a Biosimilar Market Share (2016-2018)
Table Amega Biotech Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Amega Biotech Interferon Alpha-2a Biosimilar Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Amega Biotech Interferon Alpha-2a Biosimilar Market Share (2016-2018)
Table Rhein Minapharm Biogenetics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Rhein Minapharm Biogenetics Interferon Alpha-2a Biosimilar Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Rhein Minapharm Biogenetics Interferon Alpha-2a Biosimilar Market Share (2016-2018)
Table PROBIOMED Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table PROBIOMED Interferon Alpha-2a Biosimilar Sales, Revenue, Price and Gross Margin (2016-2018)
Figure PROBIOMED Interferon Alpha-2a Biosimilar Market Share (2016-2018)
Table 3sbio Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 3sbio Interferon Alpha-2a Biosimilar Sales, Revenue, Price and Gross Margin (2016-2018)
Figure 3sbio Interferon Alpha-2a Biosimilar Market Share (2016-2018)
